Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Robotic-assisted versus manual percutaneous coronary intervention after contemporary randomized evidence: An updated systematic review and meta-analysis of patient-level procedural and radiation outcomes.

Created on 10 Nov 2026

Authors

Kumail Razvi, Maroun Ibrahim, Umer Irshad, Ramza Ishac, Zunaira Shah, Ahmad Al Taweel, Bahaeddine Shabaneh, Molham Aldeiri

Published in

Cardiovascular revascularization medicine : including molecular interventions. Nov 02, 2026. Epub Nov 02, 2026.

Abstract

Robotic-assisted PCI (R-PCI) reduces measured radiation exposure to the primary operator, but procedural and patient-radiation benefits over manual PCI (M-PCI) remain uncertain.
To compare procedural/PCI time, fluoroscopy time, contrast volume, air kerma, and dose-area product between R-PCI and M-PCI after incorporation of randomized evidence.
Randomized and nonrandomized comparative studies of adults undergoing PCI were included. Random-effects models used restricted maximum likelihood with modified Hartung-Knapp inference. Mean differences (MDs) were calculated as M-PCI minus R-PCI. Risk of bias was assessed using RoB 2 and ROBINS-I; certainty was assessed using GRADE.
Twelve studies, including 2 randomized trials, contributed data. No primary pooled outcome differed significantly: procedural/PCI time, MD -3.90 min (95% CI: -16.15 to 8.35); fluoroscopy time, 0.17 min (95% CI: -2.61 to 2.95); contrast volume, 7.79 mL (95% CI: -3.08 to 18.66); air kerma, 232.01 mGy (95% CI: -145.67 to 609.70); and dose-area product, 31.31 dGy·cm2 (95% CI: -49.45 to 112.07). Heterogeneity was substantial (I2 = 72%-93%). A direct-report-only analysis favored R-PCI for contrast volume (MD: 17.76 mL; 95% CI: 4.62-30.90), but other sensitivity analyses did not materially change interpretation. Certainty was very low for all outcomes.
R-PCI has not shown consistent patient procedural or radiation benefit. Operator protection is supported descriptively but was not pooled; contrast reduction appeared only in sensitivity analysis. Future trials should assess patient benefit and team-wide occupational exposure.

PMID:
43003731
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement